NCT02587624Completed
Remote MAGNetic Catheter Ablation for Atrial Fibrillation
Safety, Radiation Exposure and Efficacy of Remote MAGNetic Catheter Ablation for Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 1 Oct 2025
Brief summary (registry, in English)
Prospective observational single center trial, evaluating the safety, radiation exposure and efficacy of remote magnetic catheter ablation for atrial fibrillation in daily routine.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 804 (actual)
- First submitted
- 18 Oct 2015
- Start date
- Mar 2011
- Primary completion date
- Sept 2025
- Lead sponsor
- Paracelsus Medical University
- Diseases
- Atrial fibrillation
- NCT number
- NCT02587624
What you commit to
- Study type: Observational
- Participants enrolled: 804
- From Mar 2011 to the primary completion date, Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years, gravidity, breast feeding
Other
- Contraindication for AF catheter ablation
- Contraindication for magnetically guided ablation procedure
Who the study is looking for
- Consecutive patients with class I or class IIa indication for catheter ablation for symptomatic atrial fibrillation according to the current guidelines.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Paracelsus Medical University, Klinikum Nürnberg Coordinator of this site? Confirm its status | Nuremberg | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.